Breast cancer reconstruction is all too often considered nonessential, despite the fact that it addresses profound aspects of identity, confidence, and quality of life following cancer treatment. This perception reflects a broader pattern in which women’s health needs are undervalued unless they are life or death.
The path forward requires funders, practitioners, and policymakers to embed reconstruction into cancer pathways from the start, invest in training, systems, and infrastructure, and support patient networks to address stigma and disparities.
Breast cancer is the most common cancer among women worldwide, with more than 2.3 million women a year receiving a diagnosis. But the story of treatment and survivability varies drastically by location.
About the author
Contributors
Dr. Hanna Atlabachew is a plastic surgery resident with a strong interest in reconstructive, microsurgery, and breast surgery. Dr. Hellina Legesse Mamo is a plastic and reconstructive surgeon, currently working in ALERT Comprehensive Specialized Hospital, located in Addis Ababa, Ethiopia. Natalie Meyers, MPH, is executive vice president of programs and partnerships at ReSurge International, leading global efforts to expand access to reconstructive surgery. Anna Santos is the chief marketing officer at ReSurge International, leading marketing and storytelling to expand access to reconstructive surgery.
